Seres Therapeutics
Seres Therapeutics is developing revolutionary microbiome-based therapeutics to treat serious diseases.
Seres Therapeutics is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. Founded by Flagship VentureLabs, Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. Current candidates span infectious, metabolic, and inflammatory diseases.
Visit website: https://www.serestherapeutics.com/
Details last updated 23-Oct-2020
Seres Therapeutics News
Poop pill: FDA approves first microbiota capsule to fight gut infections
AP News - 26-Apr-2023
Oral formulation offers a simpler way to restore gut balance & combat recurrent C.diff infections
Read more...Nestle signs $120 million deal with Seres for ‘healthy gut’ drugs
Reuters - 11-Jan-2016
To develop and commercialize medicines aimed at restoring a healthy bacteriological balance in th...
Read more...